BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2151769)

  • 21. Induction of T cell-dependent B cell differentiation by anti-CD3 monoclonal antibodies.
    Stohl W; Posnett DN; Chiorazzi N
    J Immunol; 1987 Mar; 138(6):1667-73. PubMed ID: 2950165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different modes of T-cell activation by monoclonal antibodies to the alpha/beta T-cell receptor and the CD3 complex.
    Schlitt HJ; Schwinzer R; Wonigeit K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):147-8. PubMed ID: 2523121
    [No Abstract]   [Full Text] [Related]  

  • 23. The anti-CD6 mAb, IOR-T1, defined a new epitope on the human CD6 molecule that induces greater responsiveness in T cell receptor/CD3-mediated T cell proliferation.
    Osorio LM; Garcia CA; Jondal M; Chow SC
    Cell Immunol; 1994 Mar; 154(1):123-33. PubMed ID: 7509726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo immunosuppression induced by a weakly mitogenic antibody to mouse CD3: evidence that induction of long-lasting in vivo unresponsiveness requires TcR signaling.
    Flamand V; Donckier V; Abramowicz D; Goldman M; Vandenabeele P; Urbain J; Moser M; Leo O
    Cell Immunol; 1994 Aug; 157(1):239-48. PubMed ID: 8039247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes.
    Gangemi RM; Swack JA; Gaviria DM; Romain PL
    J Immunol; 1989 Oct; 143(8):2439-47. PubMed ID: 2794503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody.
    Jenkins MK; Chen CA; Jung G; Mueller DL; Schwartz RH
    J Immunol; 1990 Jan; 144(1):16-22. PubMed ID: 2153162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RIV-9: a mouse IgG3 anti-human CD3 monoclonal antibody with strong antigen modulating and T cell eliminating properties.
    Vaessen LM; Kreeftenberg JG; Heyse P; Leerling MF; Baumgartner D; Hendriks GF; Jutte NH; Weimer W
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1026-7. PubMed ID: 2523112
    [No Abstract]   [Full Text] [Related]  

  • 28. CD44 contributes to T cell activation.
    Huet S; Groux H; Caillou B; Valentin H; Prieur AM; Bernard A
    J Immunol; 1989 Aug; 143(3):798-801. PubMed ID: 2568380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3.
    Bonnefoy-Berard N; Revillard JP
    J Heart Lung Transplant; 1996 May; 15(5):435-42. PubMed ID: 8771497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD3-specific antibodies as promising tools to aim at immune tolerance in the clinic.
    Chatenoud L
    Int Rev Immunol; 2006; 25(3-4):215-33. PubMed ID: 16818372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
    Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
    Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid T cell receptor modulation accompanies lack of in vitro mitogenic responsiveness of double negative T cells to anti-CD3 monoclonal antibody in MRL/Mp-lpr mice.
    Davignon JL; Cohen PL; Eisenberg RA
    J Immunol; 1988 Sep; 141(6):1848-54. PubMed ID: 3262641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute toxicity of anti-CD3 monoclonal antibody in mice: a model for OKT3 first dose reactions.
    Alegre M; Depierreux M; Florquin S; Najdovski T; Vandenabeele P; Abramowicz D; Leo O; Deschodt-Lanckman M; Goldman M
    Transplant Proc; 1990 Aug; 22(4):1920-1. PubMed ID: 2143864
    [No Abstract]   [Full Text] [Related]  

  • 34. Distinct epitopes on the T cell antigen receptor of HPB-ALL tumor cells identified by monoclonal antibodies.
    Lanier LL; Ruitenberg JJ; Allison JP; Weiss A
    J Immunol; 1986 Oct; 137(7):2286-92. PubMed ID: 2428866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules.
    Smith DM; Bluestone JA; Jeyarajah DR; Newberg MH; Engelhard VH; Thistlethwaite JR; Woodle ES
    J Immunol; 1994 Aug; 153(3):1054-67. PubMed ID: 7913109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
    Damle NK; Doyle LV
    J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A common epitope on human myelin basic protein and the human T lymphocyte CD3 molecule.
    Zhang JW; Weber WE; Borst J; Vandenbark AA; Raus JC
    J Immunol; 1989 Jun; 142(11):3917-22. PubMed ID: 2469727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of the use of the monoclonal antibody OKT3 in renal transplantation.
    Norman DJ
    Transplant Proc; 1988 Dec; 20(6):1248-52. PubMed ID: 2974204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholera toxin inhibits the increase in cytoplasmic free calcium induced via the CD2 pathway of human T-lymphocyte activation.
    Nunes J; Bagnasco M; Lopez M; Olive D; Mawas C
    J Cell Biochem; 1989 Apr; 39(4):391-400. PubMed ID: 2542344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.